Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-0.08	-247.78	-247.59
Graham Fair Price	64.54	2.75	1.67
PEG	-89.72	0.04	-0.42
Price/Book	-7.30	0.61	0.65
Price/Cash Flow	11.13	-668.55	601.61
Prices/Earnings	-67.21	7.94	24.21
Price/Sales	17.21	207.42	176.97
Price/FCF	11.13	-668.55	601.61
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	97.08	-0.03	-1.01
Operating Margin	18.45	-0.82	-1.01
ROA	183.04	0.02	< 0.005
ROE	< 0.005	0.02	182.74
ROIC	< 0.005	< 0.005	54.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	-0.03	-52.47
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.90	0.34	-81.98
EPS QOQ	-0.58	1.83	218.94
FCF QOQ	1.19	-1.85	55.92
Revenue QOQ	0.15	-0.19	27.64
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3.76	7.09	88.46
Days Sales Outstanding (DSO)	492.93	76.15	-84.55
Inventory Turnover	23.91	12.69	-46.94
Debt/Capitalization	< 0.005	< 0.005	-6.27
Quick Ratio	10.29	9.24	-10.17
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.28	4.19	-2.15
Cash	0.47	0.46	-3.05
Capex	< 0.005	< 0.005	-80.84
Free Cash Flow	< 0.005	< 0.005	-18.37
Revenue	0.02	0.01	-22.60
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	10.34	10.51	1.67
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	47.69	51.84	8.68
Naive Interpretation	Member

06 - Financial Health · Bad

Rating